(Q34560645)

English

High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose methotrexate and cytarabine

scientific article

Statements

High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose methotrexate and cytarabine (English)
Jorge E Romaguera
Maria A Rodriguez
Kristine R Broglio
Frederick B Hagemeister
Peter McLaughlin
Anas Younes
Felipe Samaniego
Andreas H Sarris
Nam H Dang
Michael Wang
Virginia Beasley
L Jeffrey Medeiros
Ruth L Katz
Harish Gagneja
Barry I Samuels
Terry L Smith
Fernando F Cabanillas
6 September 2005
7013-7023

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit